Field safety notices: FLUORON
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
2 authority publications by one authority, from 22 May 2019 to 14 Jun 2019.
Latest notice: 14 Jun 2019, AEMPS, Jeringa Brilliant Peel® 0,5 ml, estériL,nº de catálogo G-81010
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by FLUORON or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- AEMPSSpainofficial source: Jeringa Brilliant Peel® 0,5 ml, estériL,nº de catálogo G-81010, AEMPS, 2019-06-14Jeringa Brilliant Peel® 0,5 ml, estériL,nº de catálogo G-81010
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- F-Octane Perfluorooctano Intraocular, Jeringa Estéril de 5 Y 7 mL ,referencia G80315 y G80317
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026